Pular para o conteúdo
Merck
  • Telomeric damage in early stage of chronic lymphocytic leukemia correlates with shelterin dysregulation.

Telomeric damage in early stage of chronic lymphocytic leukemia correlates with shelterin dysregulation.

Blood (2011-03-01)
Adeline Augereau, Claire T'kint de Roodenbeke, Thomas Simonet, Serge Bauwens, Béatrice Horard, Mary Callanan, Dominique Leroux, Laurent Jallades, Gilles Salles, Eric Gilson, Delphine Poncet
RESUMO

Cells of B-cell chronic lymphocytic leukemia (B-CLL) are characterized by short telomeres despite a low proliferative index. Because telomere length has been reported to be a valuable prognosis criteria, there is a great interest in a deep understanding of the origin and consequences of telomere dysfunction in this pathology. Cases of chromosome fusion involving extremely short telomeres have been reported at advanced stage. In the present study, we address the question of the existence of early telomere dysfunction during the B-CLL time course. In a series restricted to 23 newly diagnosed Binet stage A CLL patients compared with 12 healthy donors, we found a significant increase in recruitment of DNA-damage factors to telomeres showing telomere dysfunction in the early stage of the disease. Remarkably, the presence of dysfunctional telomeres did not correlate with telomere shortening or chromatin marks deregulation but with a down-regulation of 2 shelterin genes: ACD (coding for TPP1; P = .0464) and TINF2 (coding for TIN2; P = .0177). We propose that telomeric deprotection in the early step of CLL is not merely the consequence of telomere shortening but also of shelterin alteration.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
IgG from mouse serum, technical grade, ≥80% (SDS-PAGE), buffered aqueous solution
SKU
Tamanho da embalagem
Disponibilidade
Preço
Quantidade
Sigma-Aldrich
Anticorpo antitrimetil-histona H3 (Lys9), Upstate®, from rabbit
SKU
Tamanho da embalagem
Disponibilidade
Preço
Quantidade